This is the authors' abstract. We don't add key points for this paper.
Endogenous cyclic adenosine monophosphate (AMP) and its dibutyryl derivative increase cyclic AMP phosphodiesterase activity in cultured lymphoma cells. This effect is prevented by cycloheximide. A variant population of cells deficient in cyclic AMP-dependent protein kinase contains lower basal phosphodiesterase activity, which cannot be induced by cyclic AMP.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Bourne et al. (1973) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: